Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis

Table 2 Sorting nexin 10 expression and clinicopathologic characteristics, n (%)

Characteristic	SNX10
	High	Low	P value	χ2 value
	172 (47.5)	190 (52.5)
Age (median, yr)			0.599	0.342
≥ 60	94 (49.0)	98 (51.0)
< 60	78 (45.9)	92 (54.1)
Gender			0.385	0.755
Male	114 (46.0)	134 (54.0)
Female	58 (50.9)	56 (49.1)
Tumor size			0.566	0.330
≥ 5 cm	70 (45.8)	83 (54.2)
< 5 cm	102 (48.8)	107 (51.2)
Location			0.490	1.426
Up	33 (43.4)	43 (56.6)
Middle	46 (45.1)	56 (54.9)
Low	93 (50.5)	91 (49.5)
Bormann type			0.167	5.071
I	13 (46.4)	15 (53.6)
II	85 (52.8)	76 (47.2)
III	73 (43.7)	94 (56.3)
IV	1 (16.7)	5 (83.3)
Lauren type			0.172	3.521
Intestinal	76 (45.8)	90 (54.2)
Mixed carcinoma	35 (41.7)	49 (58.3)
Diffuse	61 (54.5)	51 (45.5)
Tumor differentiation			0.000	251.93
Moderate and high	159 (90.3)	17 (9.7)
Poor	13 (7.0)	173 (93.0)
Vessel invasion			0.264	1.246
Yes	46 (43.0)	61 (57.0)
No	126 (49.4)	129 (50.6)
Perineural invasion			0.657	0.198
Yes	40 (45.5)	48 (54.5)
No	132 (48.2)	142 (51.8)
T category			0.042	8.708
T1	40 (58.8)	28 (41.2)
T2	11 (45.8)	13 (54.2)
T3	8 (66.7)	4 (33.3)
T4	113 (43.8)	145 (56.2)
N category			0.000	18.778
N0	92 (60.5)	60 (39.5)
N1	25 (40.3)	37 (59.7)
N2	28 (41.2)	40 (58.8)
N3	27 (33.8)	53 (66.3)
TNM stage			0.001	16.744
I	44 (57.1)	33 (42.9)
II	53 (60.9)	34 (39.1)
III	73 (37.6)	121 (62.4)
IV	2 (50.0)	2 (50.0)

SNX10: Sorting nexin 10.